Cargando…
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms
Autores principales: | Li, Xian-Yang, Das, Indrajit, Lepletier, Ailin, Addala, Venkateswar, Bald, Tobias, Stannard, Kimberley, Barkauskas, Deborah, Liu, Jing, Aguilera, Amelia Roman, Takeda, Kazuyoshi, Braun, Matthias, Nakamura, Kyohei, Jacquelin, Sebastien, Lane, Steven W., Teng, Michele W.L., Dougall, William C., Smyth, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920321/ https://www.ncbi.nlm.nih.gov/pubmed/35289314 http://dx.doi.org/10.1172/JCI159825 |
Ejemplares similares
-
Thymus-derived hormonal and cellular control of cancer
por: Savino, Wilson, et al.
Publicado: (2023) -
Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity
por: Dougall, William C., et al.
Publicado: (2019) -
TREM2 marks tumor-associated macrophages
por: Nakamura, Kyohei, et al.
Publicado: (2020) -
Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development
por: Takeda, Kazuyoshi, et al.
Publicado: (2002) -
CD155, an onco‐immunologic molecule in human tumors
por: Gao, Jian, et al.
Publicado: (2017)